The phase 3 trial evaluated the efficacy and safety of cemiplimab in women 18 years of age and older with recurrent or metastatic cervical cancer, including those with either squamous cell carcinoma or adenocarcinoma.
Results of a large cohort study investigated sources of iatrogenic and noniatrogenic injuries in women coping with a potential diagnosis of cervical cancer.
Clinical trial focusing on MRI guided brachytherapy. An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer (EMBRACE)